| Mrs Donna M Gifford, OTR | |
|
1126 S 70th St, Suite South. 308b, West Allis, WI 53214-3151 | |
| (414) 456-2331 | |
| Not Available |
| Full Name | Mrs Donna M Gifford |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1126 S 70th St, West Allis, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447427653 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2872026 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Donna M Gifford, OTR 8127 Hillcrest Dr, Wauwatosa, WI 53213-2140 Ph: (414) 763-7415 | Mrs Donna M Gifford, OTR 1126 S 70th St, Suite South. 308b, West Allis, WI 53214-3151 Ph: (414) 456-2331 |
News Archive
Alimera Sciences, Inc. (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it has received a $25 million advance from Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules).
Moderate to severe depression increases the risk of heart failure by 40%, a study of nearly 63 000 Norwegians has shown. The findings were presented for the first time today at EuroHeartCare 2014.
Sigma-Tau Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the company's new drug application (NDA) for its cysteamine hydrochloride ophthalmic solution, an investigational therapy for the treatment of corneal cystine crystals in patients with cystinosis. The FDA also granted the NDA Priority Review status, a designation given to drugs that may provide major advances or a treatment where no adequate therapy exists.
Physicians who work in small, independent primary care practices-also known as SIPs-report dramatically lower levels of burnout than the national average, according to a study led by researchers at NYU School of Medicine publishing online July 9 in the Journal of the American Board of Family Medicine.
Patients with two forms of leukemia, who currently have no viable treatment options, may benefit from existing drugs developed for different types of cancer, according to a study conducted by researchers at the Knight Cancer Institute at Oregon Health & Science University.
› Verified 4 days ago
Mrs. Krystyna Andrea Apollo, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8621 W Beloit Rd, West Allis, WI 53227 Phone: 414-607-4191 | |
Mrs. Pamela Jo Sluka, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3023 S. 84th St., West Allis, WI 53227 Phone: 414-607-4100 Fax: 414-327-1834 | |
Mrs. Teresa Marie Palmisano, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9806 W Lincoln Ave, West Allis, WI 53227 Phone: 414-543-5330 | |
Jennifer Lee Mcfadyen, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8520 W Oklahoma Ave, West Allis, WI 53227 Phone: 414-607-4120 | |
Mrs. Michelle Kiefer, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 9806 W Lincoln Ave, West Allis, WI 53227 Phone: 414-543-5330 | |
Linda Jean Bolton, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10230 W Grant St, West Allis, WI 53227 Phone: 414-604-4000 | |
Megan Metzler, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-328-6647 |